… on the emergence of VIM-producing Klebsiella pneumoniae (VPKP), mainly in Southern …
antimicrobial chemotherapy for infections caused by K. pneumoniae is limited. Given the clinical …

… Introduction: Multi-drug-resistant Klebsiella pneumoniae is currently one of the most
pressing emerging issues in bacterial resistance. Treatment of K.pneumoniae infections is often …

… beta-lactamases are cephalosporinases that confer resistance to a wide variety of β-lactam …
of AmpC beta-lactamases inEscherichia coli, Klebsiella pneumoniae, andProteus mirabilis …

Extended-spectrum b-lactamase-producing Klebsiella pneumoniae in a neonatal intensive …
spectrum beta-lactamases and other enzymes providing resistance to oxyimino-betalactams. …

… demonstrated a concordant subdivision of Klebsiella pneumoniae phylogenetic group KpII
into two subgroups, KpII-A and KpII-B. Klebsiella pneumoniae clinical isolates are naturally …

… rate of extended-spectrum beta-lactamase (ESBL)-producing Klebsiella pneumoniae in the
… The incidence includes infants initially colonized with K. pneumoniae who developed active …

… Despite β-lactams serving as the cornerstone of our therapeutic armamentarium against
Klebsiella pneumoniae… diverse and clinically relevant β-lactams and β-lactamase inhibitors in K. …

… of extended-spectrum ,B-lactamase-producing K pneumoniae have been observed since
1984 (12). The sudden dissemination of a multiresistant K pneumoniae in eight different wards …

… Escherichia coli and Klebsiella pneumoniae are the two most common causative organisms
… extendedspectrum beta-lactamase (ESBL) enzymes which confer resistance to beta-lactam …

… The sequence analysis of the SHV PCR product indicated a mutation corresponding to the
SHV-5 β-lactamase. Klebsiella pneumoniae is an … Several outbreaks of infection caused by K. …